Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

No cure for female pattern hair loss, but various effective treatments exist.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Finasteride improves acne and hair loss in women with normal testosterone.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.